Medical Supervision Required: Peptide Tracker is for private logging, calculations, reminders, inventory records, and education. It is not medical advice, dosing instruction, prescribing guidance, diagnosis, or a substitute for a qualified healthcare professional.
App Guide

GLP-1 Tracker App

How Peptide Tracker helps organize GLP-1 and peptide records without replacing clinical judgment.

1. Why Use a GLP-1 Tracker App?

A GLP-1 tracker app helps turn separate dates, doses, vial details, reminders, injection sites, and notes into one readable history. KFF reported in November 2025 that 12% of U.S. adults were currently taking a GLP-1 drug, and 18% had taken one at some point.

That scale creates a practical recordkeeping problem. A person may need to remember when a dose was logged, what amount was recorded, which site was used, when inventory changed, and what notes are relevant for a clinician or pharmacist. A tracker helps keep those details from scattering across memory, screenshots, notes, and calendars.

Peptide Tracker is built around that recordkeeping role. It can help users log peptide and GLP-1 routines, view reminders, track supplies, rotate injection sites, estimate half-life curves, and export records. It does not decide whether a medication is appropriate or tell a person what dose to take.

Key Takeaways

  • KFF found 12% of U.S. adults currently used a GLP-1 drug in late 2025.
  • Peptide Tracker keeps logs, reminders, inventory, sites, calculators, and exports together.
  • The app is for records and education. Dosing decisions are outside the app.

2. What Should a GLP-1 or Peptide Log Include?

A tracking log can record time, amount, compound name, concentration context, injection site, inventory change, and notes. CDC reported in February 2026 that 40.3% of U.S. adults had obesity in August 2021-August 2023, so many GLP-1 conversations happen alongside broader metabolic health records.

The point is not to create more paperwork. The point is to make clinical conversations less dependent on memory. What changed? What was missed? Which vial is current? Which site was used last time? These questions are easier when the record has structure.

12% of U.S. adults were currently taking a GLP-1 drug in a 2025 KFF poll.
18% of U.S. adults had taken a GLP-1 drug at some point, according to KFF.
40.3% of U.S. adults age 20 and older had obesity in CDC NHANES data.

Peptide Tracker keeps the workflow private and practical. Dose history, schedules, inventory, bloodwork, injection history, and preferences can stay on the user's device by default, with optional iCloud sync handled by Apple when enabled. The developer does not need a server-side treatment log to make the app useful.

According to KFF, 76% of people who had taken GLP-1 drugs said they got them from a doctor, while 17% reported an online provider or website and 9% reported a medical spa or aesthetic medical center. That mix makes clear records especially useful when care happens across more than one setting.

3. How Peptide Tracker Organizes the Workflow

Peptide Tracker supports the practical parts of GLP-1 and peptide recordkeeping: dose logs, reminders, inventory, injection sites, calculators, half-life visualization, bloodwork records, and exportable summaries. The app has 60,000+ downloads and a 4.7 App Store rating from 189 reviews.

That feature set matters because one missed detail can change how a record reads. Was the vial reconstituted differently? Did the logged amount use milligrams, milliliters, micrograms, or syringe units? Did the next reminder reflect the actual last log? A tracker can't answer clinical questions, but it can make the source data easier to verify.

Feature What it helps record What it does not do
Dose logs Date, time, amount, compound, and notes. It does not prescribe or recommend dose changes.
Reminders Planned timing based on the user's own schedule. It does not determine clinical timing.
Inventory Supply, vial counts, and remaining amounts. It does not verify product identity or quality.
Injection site rotation Where injections were logged over time. It does not diagnose skin reactions.
Half-life curves Estimated decay using reference half-life math. It does not show measured blood concentration.

For calculations, Peptide Tracker pairs app tools with public web calculators. The peptide dose calculator handles dose-to-volume conversion, and the reconstitution calculator shows vial size, water volume, concentration, and syringe-unit math. Use these as reference tools, not instructions.

4. Why Tracking Boundaries Matter

Tracking boundaries matter because GLP-1 records often involve high-stakes medication details. FDA warned that compounded injectable semaglutide dosing errors had led some patients to draw up five to 20 times the intended dose, with some reports involving medical attention or hospitalization.

A tracker can reduce ambiguity in the user's own record, but it cannot validate a product, confirm a prescription, assess side effects, or choose a dose. It also cannot know whether a compounded product, vial label, or online source is appropriate. Those checks belong with licensed clinicians, pharmacists, and regulated pharmacies.

FDA has also warned about counterfeit Ozempic in the U.S. supply chain. In April 2025, FDA said several hundred counterfeit 1 mg units had entered the supply chain outside Novo Nordisk's authorized distribution. In December 2025, FDA reported another counterfeit Ozempic alert involving dozens of units.

Practical Tracking Boundary

A GLP-1 tracker can make uncertainty more visible instead of hiding it. If a dose, unit, product source, concentration, or instruction is unclear, the record can preserve that uncertainty rather than forcing a false sense of precision.

This is why Peptide Tracker's wording separates math and logging from medical decision-making. The app helps maintain records, visualize schedules, and prepare cleaner exports. It does not turn a calculation into clinical advice.

5. What Does Half-Life Tracking Add?

Half-life tracking adds a visual estimate of how logged entries overlap over time. DailyMed lists semaglutide's elimination half-life as approximately 1 week, with semaglutide present in circulation for about 5 to 7 weeks after the last Wegovy dose; Zepbound's tirzepatide half-life is listed at about 5 to 6 days.

That difference affects how curves look. A longer reference half-life creates more overlap between logs, while a shorter reference half-life declines faster in the model. The curve is useful for education and schedule readability, but it is not a lab result.

For a deeper explanation of the formula, accumulation, and steady-state estimates, see the peptide half-life tracking guide. That page breaks down the exponential decay model and shows why "remaining amount" is not the same as individualized medical clearance.

Half-life visualization is most helpful when it sits next to the ordinary log. The log answers "what did I record?" The curve answers "how does the reference model display overlap?" Those are different questions, and keeping them separate prevents overinterpretation.

6. When Are Exports and Notes Useful?

Exports are useful when a person needs to review patterns outside the app. KFF found that 56% of GLP-1 users in its 2025 poll said the medications were difficult to afford, and 14% of users had stopped because of cost. A clean record can help frame practical conversations about continuity.

Notes can capture context that a number alone misses. Examples include a missed reminder, a supply issue, a site reaction, a pharmacy question, or a clinician instruction entered for reference. Factual, dated notes make the timeline easier to read.

A useful tracking export is not necessarily the longest one. It is the one that makes the timeline easier to reconstruct: what was logged, when it was logged, what unit was used, which product or vial was involved, and what questions remain open.

7. How Does Privacy Fit Into GLP-1 Tracking?

Privacy matters because GLP-1 and peptide logs can reveal health conditions, medication access, costs, prescribing relationships, and body-weight goals. Peptide Tracker stores data locally by default, and optional iCloud sync uses the user's Apple account rather than a developer-operated treatment database.

That architecture fits the job. A tracker does not need to monetize or analyze treatment behavior to help a user remember what happened. Users who want more detail can review the Privacy Policy and the broader About Peptide Tracker page.

8. GLP-1 Tracker App FAQ

9. Sources

Download Peptide Tracker